Similar Items: A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms
- A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication Satisfaction
- What does it take to make real‐world changes in schizophrenia care?
- Pilot Study of Behavioral Activation Treatment for Negative Symptoms in Older Adults With Schizophrenia Spectrum Disorder
- “Dream Insertion”: A Case Report of a Novel Psychotic Symptom in a Male Inpatient With Treatment Resistant Schizophrenia
- The Lived Experience of Cognitive Impairment Associated With Schizophrenia: A Conceptual Model
- Validation and Functional Exploration of Exosome-Derived ITGA9-AS1 and WNT5A-AS1 as Candidate Diagnostic Biomarkers for Schizophrenia